Rare Disease And Orphan Drug Regulation In Japan
The Orphan Druganaut Blog continues its review of international rare disease and orphan drug regulations with a look at Japan. Last week we looked at Australia.
Intractable & Rare Diseases Research is a peer-reviewed journal of the International Research and Cooperation Association for Bio & Socio-Sciences Advancement that is published quarterly. A fact-filled and fascinating article on the status of rare diseases and orphan drugs in Asian countries can be found in this journal :
Peipei Song et al. “Rare Diseases, Orphan Drugs, And Their Regulation In Asia: Current Status and Future Perspectives”, Intractable & Rare Diseases Research. 2012; 1(1):3-9.
Below are a few categories for comparing rare disease and orphan drug definitions, legislation, and regulations for Japan vs. the United States :
Definition of Rare Diseases
– US: Prevalence of < 0.75% (effects < 200,000)
– Japan: Prevalence of < 0.40% (effects < 50,000)
Population Size
– US: 25-30 Million
– Japan: No information available
Legislation
– US: Orphan Drug Act (1983) & Rare Disease Act of 2002
– Japan: Revised orphan drug regulations (Amendment of the Pharmaceutical Affairs Act & Drug Fund for Adverse Reaction Relief & Research Promotion Act – 1993)
Marketing Exclusivity
– US: 7 years
– Japan: 10 years (6 years for non-orphan drugs)
Tax Credits
– US: Up to 50% for clinical expenses
– Japan: up to 50% of expenses for clinical & non-clinical research; 15% tax credits, up to 14% corporate tax reduction
Fast Track Approval
– US: Yes
– Japan: Yes.
Additional statistics about rare diseases and orphan drugs in Japan :
– Almost 50% of orphan drugs on japanese market originated from EU or US
– 56 of 130 (approximately 43%) designated diseases are subject to reimbursement of medical expenses, with 30% paid by insurance companies, and the rest paid by national &prefectures governments.
References
Intractactable Disease Information Center
Japan’s Ministry of Health, Labour, & Welfare: Overview of Orphan Drug/Medical device Designation System
OrphaNet article on “Orphan Drugs in Japan”
Copyright © 2012-2013, Orphan Druganaut Blog. All rights reserved.